Indications and uses
Helps in the prevention of premature ejaculation.
PROLONG
- Manufacturer
- Product Max Group Inc
- Effective date
- 2016-08-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:46:43
Label at a glance#
ProductPROLONG
Active ingredientBENZOCAINE
Label structure9 sections
Dosage and administration
Apply a small amount to head and shaft of penis before intercourse. Wash product off after intercourse.
Contacts and useful links#
Websitewww.bodyactionproducts.com
www.bodyactionproducts.com
www.bodyactionproducts.comLabel contents#
Full prescribing information#
Drug FactsActive Ingredient
Benzocaine 5%
Purpose
Male Genital Desensitizer
Keep out of reach of children
Keep out of reach of children.
If swallowed get medical help or contact a Poison Control Center right away.
Uses
- Helps in the prevention of premature ejaculation.
Warnings
For external use only.
- Avoid contact with the eyes.
- Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor.
- If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.
Directions
- Apply a small amount to head and shaft of penis before intercourse.
- Wash product off after intercourse.
Other Information
Do not use if safety seal under cap is broken or missing.
Inactive Ingredients
Hydroxyethylcellulose, Methylparaben, PEG-8, Propylene Glycol, Propylparaben, Water
PROLONG product label
Distributed by:
Body Action Products
Lutz, FL 33559
ACTION BODY PRODUCTS
Benzocaine Male Genital Desensitizer
PROLONG
FOR MEN
Helps Prolong Sexual Pleasure
Lubricating Gel
2 FL OZ (60 ml)
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| BENZOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3c386306-c48a-413e-bb69-70cb268496f3 | Product name | 1 | 20210727 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70742-089-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-cff1-f424-e053-dadaa90a57ce | PROLONG - 089 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70742-089-01 | PROLONG | 60 mL in 1 BOTTLE | GEL | 60 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- PROLONG
- BENZOCAINE
- HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)
- METHYLPARABEN
- POLYETHYLENE GLYCOL 400
- PROPYLENE GLYCOL
- PROPYLPARABEN
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70742-089 | 70742-089-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BENZOCAINE | U3RSY48JW5 | ACTIB |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0e144306-e60f-4de8-a6cb-70882bd85db8 | 014000ad-2500-44ee-b593-6f5fe189757e | 2016-08-07 | Warnings | 0e144306-e60f-4de8-a6cb-70882bd85db8 014000ad-2500-44ee-b593-6f5fe189757e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.